Best Insel Podcasts (2024)

1
Comparing Psychedelic Compounds in Therapy (Live Panel at Battery SF) 1:01:53

9d ago1:01:53

1:01:53

Matias hosted a panel at The Battery SF with renowned psychedelics experts, Nolan Williams, Allison Feduccia, Matt Baggott. Nolan is a Stanford professor currently researching ibogaine among other areas in psychiatry and radiology, and he's a founder of TMS company Magnus Medical. Allison is the founder of Psychedelic Support, a platform providing …

1
What Payers Want with Lili Brillstein 48:20

1M ago48:20

48:20

Matias interviews Lili Brillstein about how to work collaboratively with healthcare payers (the ones that reimburse for medical expenses). Lili is a pioneer in the field, having previously led one of the largest bundled payment initiatives at Horizon Blue Cross Blue Shield. She currently is the founder of her own advisory firm, BCollaborative, wher…

1
Decoding the Brain with Ed Boyden 50:37

2M ago50:37

50:37

Greg and Matias interview Ed Boyden about neuroscience frontiers and its applications to mental health. Ed is a pioneer in understanding the fundamental mechanisms of the brain. He runs a lab at MIT for Synthetic Neurobiology and is a professor across the departments of neurotechnology, biological engineering, and cognitive science at MIT’s McGover…

1
5-MeO-DMT in mental healthcare with Steve Rio 50:25

3M ago50:25

50:25

Greg and Matias interview Steve Rio about 5-MeO-DMT and its potential role in mental healthcare. Steve is a social impact cofounder, transformational coach, and practitioner at the Enfold Institute, one of the most reputable aboveground retreat centers working with 5-MeO-DMT. He shared many insights from his hands-on experience guiding hundreds of …

1
Tom Insel: Startups, AI, Psychedelics, and SSRIs 57:50

4M ago57:50

57:50

Tom Insel is an entrepreneur and former director of the US National Institute of Mental Health, the lead US agency supporting mental health research with a $2 billion budget. Since his time at the NIMH, Tom has built mental health technology, first at Verily and Mindstrong Health, and more recently founded Vanna Health, an online healthcare provide…

1
Food as Medicine for Mental Health: Drew Ramsey 46:19

5M ago46:19

46:19

What if your next antidepressant was a clam or spinach? Greg & Matias invite Dr. Drew Ramsey to explore nutritional psychiatry - a field exploring how the food we eat can be as powerful as medication in treating mental illnesses like depression and anxiety. Dr. Drew Ramsey is a psychiatrist, entrepreneur and author focusing on nutritional intervent…

1
Ketogenic Diet for Brain Health: Jan Baszucki 44:19

5M ago44:19

44:19

Can diet treat mental illness? Greg and Matias interview Jan Baszucki of the Baszucki Group whose son Matt overcame bipolar through the ketogenic diet. Jan has supported studies on ketogenic diets and fasting protocols for conditions like depression, schizophrenia, and bipolar disorder. In this episode we discuss: The powerful personal story behind…

1
Investing in Neurotech 101: Alex Morgan of Khosla Ventures 54:38

6M ago54:38

54:38

Advancements in neuroscience, AI, and bioengineering are unlocking new possibilities for neurotechnologies. Investors are paying attention. Alex Morgan of Khosla Ventures is an MD, PhD, physicist, and one of the most active investors in neurotech startups. He's backed companies harnessing neuromodulation for varied applications - from sleep (Somnee…

1
All you need is d̶r̶u̶g̶s̶ energy: Motif Neurotech's Implants for Depression 55:00

6M ago55:00

55:00

Neuromodulation flies in the face of modern psychiatry. It can significantly improve mental health without drugs. It allows us to stimulate or inhibit activity in precise regions of the brain using electricity, magnetism or ultrasound. Motif Neurotech is pioneering minimally invasive implants to precisely deliver neuromodulation for mental health. …

1
Holy poop! Mental health and the gut (part 2 with Bloom Science) 40:15

7M ago40:15

40:15

In part 2 of a 2-part series, Greg and Matias explore microbial therapeutics for mental health with Dr. Christopher Reyes, biophysist, serial enterepreneur, and founder of Bloom Science. Dr. Reyes' research on leveraging microbes to treat neurological conditions began at UC San Francisco. He is now translating his microbiome research into startups …

1
Holy poop! Mental health and the gut (part 1 with Holobiome) 48:48

7M ago48:48

48:48

Business Trip launched in 2020 as a podcast focused on psychedelics. As Matias and Greg started to dive deeper into the complexities of mental health, they met more and more entrepreneurs and scientists creating novel treatments across many areas of mental health, including the gut microbiome. Dr. Phil Strandwitz pulls back the curtain on the gut-b…

1
Ketamine for OCD: Carolyn Rodriguez (Stanford pt 3) 38:28

8M ago38:28

38:28

Stanford University is one of the leading universities in psychedelic science, focusing on understanding how psychedelics work in the body. This is part 3 of a 3-part series, where we will explore groundbreaking discoveries via leading Stanford researchers who are revealing the significance of psychedelic science in modern research. We conclude the…

1
Are psychedelics effective under anesthesia?: Boris Heifets (Stanford pt 2) 37:28

8M ago37:28

37:28

Stanford University is one of the leading universities in psychedelic science, focusing on understanding how psychedelics work in the body. This is part 2 of a 3-part series, where we will explore groundbreaking discoveries via leading Stanford researchers who are revealing the significance of psychedelic science in modern research. We continue wit…

1
The Startup Landscape for Expanding Consciousness 1:21:12

9M ago1:21:12

1:21:12

Psychedelics have long been known to induce altered states of consciousness. But there are many other techniques that can also expand our awareness - from meditation and breathwork to exploring dreams, prayer, light and sound. In this episode, Greg speaks with Scott Britton about the emerging startup landscape around tools for expanding consciousne…

1
Stanford Psychedelic Overview: Robert Malenka (Stanford pt 1) 51:18

9M ago51:18

51:18

Stanford University is one of the leading universities in psychedelic science, focusing on understanding how psychedelics work in the body. In this 3-part series, we will explore groundbreaking discoveries via leading Stanford researchers who are revealing the significance of psychedelic science in modern research. We start the series with Robert M…

1
Live from Psychedelic Science 2023 56:44

10M ago56:44

56:44

Psychedelic Science 2023, Learning Man, MAPS Burn...whatever you want to call it...was a magical conference organized by MAPS. 12k people made the pilgrimage to Denver to discuss psychedelic science, culture, business, art, spirituality, and more. Rick Doblin called this the "Psychedelic 20's" and this event felt like a watershed moment. Luckily, G…

1
What VCs Look for in Psychedelic Companies 41:57

11M ago41:57

41:57

What does it take for a traditional VC to fund a psychedelic company? In our latest episode, Matias takes us behind the scenes of a panel discussion at the Psychedelic Therapeutics & Drug Development Conference in San Francisco, CA. Matias talks with VCs at firms with $100M+ fund sizes: Anne Dwane, a partner at Village Global, Amanda Way, principal…

1
S4E10: Julie Gerberding - Championing Public Health 43:00

11M ago43:00

43:00

We close out the fourth season with Dr. Julie Gerberding, the former CDC director, the current CEO of the Foundation for the National Institutes of Health, and one of the pre-eminent infectious disease physicians in the country. In this interview, Dr. Gerberding discusses pursuing a career in public health, lessons from her time as CDC director, an…

1
S4E09: Jess Mega - Academia to Private Industry 45:29

12M ago45:29

45:29

Dr. Jess Mega, a prominent practicing cardiologist and healthcare executive, joins the podcast to discuss her career in patient care, clinical trials, and healthcare innovation. With her experience as a Harvard and Stanford Cardiologist, founder of Verily Life Sciences, a CMO and CSO of Verily, and a member of the board of the Danaher Corporation, …

1
Developing Non-Hallucinogenic Psychedelics: Bryan Roth 49:55

12M ago49:55

49:55

In our latest episode, Greg and Matias engage in an insightful discussion with Dr. Bryan Roth, the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Chapel Hill School of Medicine, and the founder of the Roth Lab. Dr. Roth’s lab is on the cutting edge of researching the interaction between brain cell recepto…

1
S4E08: Thomas Insel - Mental Health Access 52:35

12M ago52:35

52:35

We are joined by Dr. Thomas Insel, a psychiatrist, author and neuroscientist who is a leading expert on mental health. Dr. Insel is the former director of the National Institute of Mental Health and founder of Vanna Health-- a startup that aims to expand access to comprehensive care for serious mental illness. We start the conversation by discussin…

1
S4E07: Michael Pfeffer - Clinical Informatics and Adopting Healthcare Technology 46:16

1y ago46:16

46:16

Stanford Health Care Chief Information Officer and internal medicine physician Dr. Michael Pfeffer discusses the role of a CIO at a large health system, clinical informatics, and adopting technology solutions in healthcare. Join for a conversation on accelerants and barriers toward technology innovations in healthcare and advice for entrepreneurs l…

1
Behind the Scenes of PsyMed Ventures 35:49

1y ago35:49

35:49

In this week's episode, Greg and Matias take a moment to reflect on the opportunities and challenges they have faced while building the PsyMed Ventures syndicate and venture capital fund since starting the Business Trip podcast in 2020. Their ultimate goal is to support founders who are building ethical businesses in frontier mental health technolo…

1
S4E06: Michael Howell - Clinical Medicine in Big Tech 40:50

1y ago40:50

40:50

Google Chief Clinical Officer Dr. Michael Howell joins this week for a conversation on building clinical careers in tech and the role of big tech companies like Alphabet in healthcare. In this interview, Howell discusses his recent piece in NEJM Catalyst on building successful clinical teams in large tech companies and the role of clinical teams in…

1
S4E05: Jeffrey Kang - Ushering Value Based Care 47:49

1y ago47:49

47:49

Dr. Jeffrey Kang– Geriatrician, former CMO of CMS, former CMO of Cigna, former executive at Walgreens and ChenMed, and now CEO of at-home primary care startup Wellbe Senior Medical– joins for an in-depth conversation on how to usher value based care innovations in the healthcare system. As the first Chief Medical Officer of CMS, Kang pioneered HCC …

1
S4E04: Patrick Carroll - Consumer Driven Healthcare 46:22

1y ago46:22

46:22

Dr. Patrick Carroll, Family Medicine Physician and Chief Medical Officer of Hims & Hers, joins for an enriching conversation on consumer-driven healthcare, population health and value-based care. Carroll discusses his journey starting out as a primary care physician working with the Indian Health Service and extending that ground level work to beco…

1
The 2023 Psychedelic Industry Landscape with Psychedelic Alpha 49:51

1y ago49:51

49:51

In this week’s episode, Greg and Matias chat with Josh Hardman, the founder of Psychedelic Alpha. Josh is a leading writer and founder at Psychedelic Alpha, an online resource, newsletter, and community covering the intersection of psychedelics and business. He regularly collaborates and writes with experts in the psychedelic field including entrep…

1
S4E03: Amira Barkal - Commercializing Science During Clinical Training 47:10

1y ago47:10

47:10

Physician scientist and oncologist in training Dr. Amira Barkal discusses her extraordinary journey commercializing scientific discoveries she made with Dr. Irving Weissman during MD/PhD at Stanford. Barkal went on to raise $76M as founder and CEO of Pheast Therapeutics, all while completing her residency at Brigham and Women's Hospital. Join for a…

1
S4E02: Paul Rothman - Reflections of an Academic Medical Center CEO 53:22

1y ago53:22

53:22

Physician scientist and rheumatologist Dr. Paul Rothman joins for a reflective conversation as he completes his 10 year tenure as CEO of Johns Hopkins Medicine and the Dean of the Johns Hopkins University School of Medicine. Join for a rich discussion on leadership, management, navigating transitions from medical to administrative careers, and the …

1
The State of Psychedelics (Part 2): Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House) 53:54

1+ y ago53:54

53:54

In this week’s special episode, Matias chats with Dr. Rachel Yehuda and Zach Haigney at Soho House in New York City. This is part 2 of a moderated panel recorded in front of a live audience, with part 1 released in June 2022. Dr. Yehuda has spent the last 30 years doing research on PTSD and trauma and is leading the MDMA-assisted therapy research a…

1
S4E01: David Mou - Leading through Challenges 47:23

1+ y ago47:23

47:23

Dr. David Mou, the CEO and former CMO of the telehealth psychiatry startup Cerebral, discusses guiding his company through DOJ investigations into controlled substance prescribing practices and market headwinds months after raising a $300M Series C at a $4.8B valuation. A Harvard-trained psychiatrist, Mou has a conversation about Cerebral's mission…

1
The quest to improve MDMA 55:29

1+ y ago55:29

55:29

This episode shares the story of Tactogen, a drug development company making new chemical entities inspired by MDMA. Co-founder Matt Baggott has been fascinated by MDMA and has studied it for 30 years. And while he believes that MDMA can be effective as a therapeutic, his company is developing an MDMA analogue that is designed to be gentler and saf…

1
Blasphemische Zeiten 1:15:08

1+ y ago1:15:08

1:15:08

Unser Rückblick auf - WTCS Grand Final Abu Dhabi- IM Israel, Arizona, Cozumel...- Das Ende des Mythos vom IM Hawaii?By Gregor Buchholz

1
Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment 50:05

1+ y ago50:05

50:05

In this new episode of Business Trip, we interview one of the first clinics to offer a protocol that includes TMS (transcranial magnetic stimulation) and ketamine infusion. TMS is a non-invasive procedure that sends electric currents to specific regions in the brain, including areas linked to depression. It's FDA approved and has been gaining adopt…

1
Wüste, Wüste, Insel 1:12:06

1+ y ago1:12:06

1:12:06

Sport inside - der Podcast Haft in Russland: Das Schicksal von US-Superstar Britney Grinerhttps://podcasts.apple.com/de/podcast/sport-inside-der-podcast/id1546865418?i=1000567629334 Zeit Online Geld Macht Katar https://podcasts.apple.com/de/podcast/geld-macht-katar/id1644039728By Gregor Buchholz

1
Perspectives from Christian Angermayer, investor and founder in psychedelics 42:34

1+ y ago42:34

42:34

In this week's episode, we chat with Christian Angermayer. Christian co-founded atai Life Sciences and was an early investor in Compass Pathways -- two of the first companies commercializing psychedelic medicine. Christian also launched a fund dedicated to mental and neurological health called re:Mind, is an investor through his family office Apeir…

1
Könnte ein Kona Review sein 1:10:45

1+ y ago1:10:45

1:10:45

Long time no hear! Aber wenn nach zwei wieder Kona am Start ist, sind wir es ebenfallsBy Gregor Buchholz

1
Soltara: an ethical and profitable ayahuasca retreat 54:34

1+ y ago54:34

54:34

In this week’s episode, we chat with Melissa Stangl, co-founder of Soltara Healing Center. Soltara is an ayahuasca retreat center whose ceremonies are lead by Shipibo healers, with locations in Peru and Costa Rica. The Shipibo people are from the Peruvian Amazon and are part of a tradition that has been drinking Ayahuasca for healing and spiritual …

1
Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics 58:24

1+ y ago58:24

58:24

This is final episode in our 3-part series on microdosing that explores the science, history, and clinical applications. In this episode, we discuss the path to FDA approval for microdosing. We chat with the chief medical officers from Diamond Therapeutics and MindMed about their microdosing clinical programs. Diamond's program uses synthetic psilo…

1
Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti 37:28

1+ y ago37:28

37:28

This is part 2 or our 3 part series on microdosing that explore the science, history, and clinical applications. In part 1, we interviewed psychedelic researcher James Fadiman about the fundamentals of microdosing. In part 2, we wanted to understand the placebo effect. In particular, is it the microdose that makes people feel better or it is a plac…

1
Microdosing (part 1): James Fadiman and the fundamentals of microdosing 33:06

1+ y ago33:06

33:06

In this 3-part series on microdosing, we explore the science, history, and its clinical potential. The anecdotal benefits of microdosing include better mood, creativity, and increased focus. But there are still many unanswered questions that remain. What is an effective dosing protocol? Is it safe in long term use? Does it even work or is it a plac…

1
PTO Canadian Open Special 46:45

1+ y ago46:45

46:45

Zum ersten Mal PTO Canadian Open auf bekannten Terrain. Wir besprechen das Rennen in EdmontonBy Gregor Buchholz

1
Im Spotlight ist alles 1:25:57

2y ago1:25:57

1:25:57

Wir müssen vieles aufholen! Erstmal ein Kurzstreckenblock von Leeds bis zu den Finals und dann die Langstreckenrennen Frankfurt und RothBy Gregor Buchholz

1
How the DEA and FDA will regulate psychedelic medicine 48:51

2y ago48:51

48:51

In this week’s episode, we chat with Matt Zorn, an attorney at Yetter Coleman with expertise in DEA law, especially regarding psychedelics. Matt is currently challenging the DEA’s decision to schedule 5 new tryptamines, he recently argued Kathryn Tucker’s psilocybin “Right To Try” case against the DEA, and previously co-led Sue Sisley’s DEA case re…

1
Sub 1h7min Episode 1:07:07

2y ago1:07:07

1:07:07

Im Vorfeld heiß umstritten, widmen auch wir uns nun dem Sub7Sub8 Projekt.... und natürlich anderen RennenBy Gregor Buchholz

1
The state of psychedelics: Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House) 45:45

2y ago45:45

45:45

In this week’s special episode, Matias chats with Dr. Rachel Yehuda and Zach Haigney at Soho House in New York City. The episode was recorded in front of a live audience. Dr. Yehuda has spent the last 30 years doing research on PTSD and trauma and is leading the MDMA-assisted therapy research at the US Veterans Affairs Medical Center. She is the Di…

1
Empowering the next wave of psychedelic therapists: Journey Clinical 41:41

2y ago41:41

41:41

In Episode 18, we chat with Jonathan Sabbagh and Myriam Barthes, the co-founders of Journey Clinical, a platform that enables licensed therapists to offer ketamine-assisted psychotherapy (KAP). Journey Clinical provides licensed therapists with an on-demand KAP-trained medical team, customized treatments for each client, and a portal to connect wit…

1
Das GOAT Problem 1:10:57

2y ago1:10:57

1:10:57

Zwei WM Titel - einer neu und der andere auch irgendwie neu - und dazu historische Leistungen.By Gregor Buchholz

1
S3E10: Aaron Ring - Becoming a Scientific Founder 44:01

2y ago44:01

44:01

Yale Immunobiology Professor and Scientific Founder of Simcha Therapeutics and Seranova Bio, Dr. Aaron Ring, discusses his journey starting a lab spinning out companies building therapeutics for patients right out of his MD/PhD program. We close out the final episode of the season with a conversation around generating leading science with translati…

1
Osmind and the future of electronic health records in psychedelic medicine 36:19

2y ago36:19

36:19

In today’s episode, we chat with Lucia Huang, the CEO and co-founder of Osmind, an electronic health record software system for treatment resistant mental health practices that is already in over 300 clinics. In this episode, we discuss: How Osmind makes data-driven decisions Osmind’s quick growth in only 2 years What it will take for insurance to …

Podcasts Worth a Listen

Insel Podcasts

Podcasts Worth a Listen

Quick Reference Guide